vTv Therapeutics.

PositionTRIAD BRIEFS: HIGH POINT

Billionaire Ronald Perelman's MacAndrews & Forbes bought an additional 50,000 shares of vTv Therapeutics, increasing its company holdings to more than $14 million in early January. The drugmaker is developing...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT